Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov;24(11):1433-1441.
doi: 10.1007/s11912-022-01291-3. Epub 2022 Jun 7.

Minimally Invasive Procedures in the Diagnosis and Treatment of Localized Prostate Cancer: an Interventional Radiologist's Perspective

Affiliations
Review

Minimally Invasive Procedures in the Diagnosis and Treatment of Localized Prostate Cancer: an Interventional Radiologist's Perspective

Yaniv Avital et al. Curr Oncol Rep. 2022 Nov.

Abstract

Purpose of review: Minimal invasive procedures, including targeted biopsy (TB) and focal therapy (FT), are increasingly used in diagnosis and treatment of localized prostate cancer. Here, we review the current role of these procedures, from a perspective of an interventional radiologist.

Recent findings: TB is an established part of current guidelines for diagnosis of PCa. Several modalities of FT are gaining prevalence in recent years, as a tissue-preserving alternative for definitive treatment of localized PCa. FT is currently at early research stages, offered to selected patients in clinical trials settings. TB and FT are minimally invasive procedures used by multidisciplinary teams for diagnosis and treatment of localized PCa.

Keywords: Focal therapy; Interventional radiology; Localized prostate carcinoma; Multi-parametric MRI; Partial gland ablation; Targeted biopsy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
FT and partial gland ablative template. Focal therapy: Focused ablation of an image-visible index lesion. Partial gland ablation: destruction of all prostate tissue within an anatomical ablation zone, aiming to preserve at least one neurovascular bundle. Ablation templates include as follows: Quadrant ablation — a quadrant of the prostate tissue; Hemi-ablation — a lateralized hemisphere of the prostate or the anterior half of the prostate; Hockey stick ablation — prostate tissue within a lateralized hemisphere plus anterior contralateral region; Subtotal ablation — most of the prostate tissue with preservation of a posterior lateral region (unilaterally or bilaterally)
Fig. 2
Fig. 2
A 68-year-old male presenting with an elevated PSA level of 5 ng/mL was diagnosed with prostate cancer in the right peripheral zone in the midportion of his prostate, Gleason score of 3 + 4 = 7 (ISUP 2). a T2-weighted MR image of the lesion before treatment. b Contrast enhanced image directly at the end of the focal laser ablation procedure, showing lack of enhancement at the ablation bed. At 1-year follow-up after treatment, the patient’s PSA level dropped to 2.2 ng/mL and the following MRI images confirmed no evidence of residual or recurrent tumor at the treatment area: c Perfusion weighted color MR image, showing lack of perfusion in the treated area. d T2-weighted MR image, showing complete focal atrophy of the treated area

References

    1. • EAU guidelines. Edn. presented at the EAU Annual Congress Milan 2021. 2021.8. Integration of current data regarding diagnosis of PCa and treatment of localized PCa into the current EAU guidelines.
    1. Borges RC, et al. Impact of focal versus whole gland ablation for prostate cancer on sexual function and urinary continence. J Urol. 2021;205(1):129–136. - PubMed
    1. Padhani AR, et al. PI-RADS Steering Committee: the PI-RADS multiparametric MRI and MRI-directed biopsy pathway. Radiology. 2019;292(2):464–474. - PMC - PubMed
    1. Rouvière O, et al. Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study. Lancet Oncol. 2019;20(1):100–109. - PubMed
    1. Kasivisvanathan V, et al. MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med. 2018;378(19):1767–1777. - PMC - PubMed